IndraLab

Statements

Docetaxel anhydrous inhibits FURIN. 1 / 1

| 1

reach

"The clinical efficacy of PACE seems to be more slightly lower in patients previously treated with docetaxel, which suggest that paclitaxel may have cross resistance to docetaxel."

21888637

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Docetaxel anhydrous inhibits FURIN. 1 / 1

INDRA sources:

Databases

Reading